Request Deal Involvement

Investor-backed SOBI completed the acquisition of CTI BioPharma for $1.7bn.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Latham & Watkins

legal advisors

Latham & Watkins

Danske Bank

debt providers

Danske Bank

Bank of America

debt providers

Bank of America

Mannheimer Swartling

legal advisors

Mannheimer Swartling

Bank of America

financial advisors

Bank of America

White & Case

legal advisors to financial advisors

White & Case

Linklaters

legal advisors

Linklaters

Gibson Dunn & Crutcher

legal advisors

Gibson Dunn & Crutcher

Skadden Arps Slate Meagher & Flom

legal advisors

Skadden Arps Slate Meagher & Flom

Joele Frank

pr advisors

Joele Frank

Centerview Partners

financial advisors

Centerview Partners

Paul Weiss Rifkind Wharton & Garrison

legal advisors to financial advisors

Paul Weiss Rifkind Wharton & Garrison

MTS Health Partners

financial advisors

MTS Health Partners

or

Principals

SWEDISH ORPHAN BIOVITRUM AB (SOBI)

bidder

SWEDISH ORPHAN BIOVITRUM AB (SOBI)

INVESTOR AB

bidder

INVESTOR AB

CTI BIOPHARMA

target

CTI BIOPHARMA

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Investor-backed SOBI completed the acquisition of CTI BioPharma for $1.7bn.